Caxton Associates (UK)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.25M Buy
47,260
+8,522
+22% +$395K 0.04% 233
2026
Q1
$1.7M Buy
+38,738
New +$1.77M 0.04% 256
2025
Q4
Sell
-13,471
Closed -$569K 917
2025
Q3
$569K Sell
13,471
-44,682
-77% -$1.8M 0.01% 433
2025
Q2
$2.13M Buy
58,153
+1,561
+3% +$58K 0.05% 177
2025
Q1
$2.16M Buy
+56,592
New +$2.11M 0.08% 143

Other funds holding OHI

Caxton Associates (UK)'s OHI Position: Q2 2026 in Review

Caxton Associates (UK) increased its Omega Healthcare (OHI) stake by 22% in Q2 2026, buying an estimated $395K and bringing the position to 47,260 shares worth $2.25M. The position accounts for 0.04% of the portfolio, ranked #233.

Caxton Associates (UK) first reported a position in OHI in Q1 2025 and has held it in 5 quarters since. 761 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Caxton Associates (UK) held 47,260 shares of Omega Healthcare worth $2.25M as of Q2 2026.
  • Caxton Associates (UK) bought 8,522 Omega Healthcare shares in Q2 2026, an estimated $395K.
  • Omega Healthcare made up 0.04% of Caxton Associates (UK)'s portfolio in Q2 2026, its #233 holding.
  • Caxton Associates (UK) first reported a position in Omega Healthcare in Q1 2025 and has held it in 5 quarters since.
  • 761 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.